Replies to post #14466 on ANI Pharmaceuticals (ANIP)

[silvr_surfr]

Thank you JTFM. This seems like an important point of differentiation. Sometimes the follower can leapfrog the first to market product.

[silvr_surfr]

I think ANIP is serious about meeting unmet customer needs. I don't think it is a coincidence that hydroxychloroquine is used in the treatment of Interstitial Lung Disease in children, but there is no available dosage (until now) for them even off label. I also like that they are staying in their domain (in this case pulmonology) within rare diseases.

Here is a write up on ILD:

Interstitial Lung Disease